Petr Riha

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

TCF3::HLF Fusion Gene in a Pediatric B-Cell Lymphoblastic Lymphoma With Multifocal Osteolytic Lesions: Expanding the Clinical and Molecular Landscape.

TCF3::HLF Fusion Gene in a Pediatric B-Cell Lymphoblastic Lymphoma With Multifocal Osteolytic Lesions: Expanding the Clinical and Molecular Landscape.

Journal: Pediatric blood & cancer

Published: October 29, 2025

Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study.

Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study.

Journal: Blood

Published: July 23, 2025

Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT.

Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT.

Journal: Blood

Published: July 23, 2025

CD4+ Memory Stem-Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long-Term Morbidity and Mortality After Hematopoietic Cell Transplantation.

CD4+ Memory Stem-Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long-Term Morbidity and Mortality After Hematopoietic Cell Transplantation.

Journal: Pediatric blood & cancer

Published: June 24, 2025

Beyond TREC: Pivotal role of tandem TREC/KREC assay in Czech SCID NBS pilot programme.

Beyond TREC: Pivotal role of tandem TREC/KREC assay in Czech SCID NBS pilot programme.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: February 25, 2025

NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk.

NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk.

Journal: HemaSphere

Published: November 22, 2024

Resolution of granulomatous lesions in a Nijmegen breakage syndrome patient with severe immunodeficiency after hematopoietic stem cell transplantation.

Resolution of granulomatous lesions in a Nijmegen breakage syndrome patient with severe immunodeficiency after hematopoietic stem cell transplantation.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: July 31, 2024

CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics.

CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics.

Journal: Pediatric blood & cancer

Published: January 10, 2022

Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study.

Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study.

Journal: Bone marrow transplantation

Published: November 17, 2021

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood.

Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood.

Journal: Neoplasma

Published: February 14, 2020

Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement.

Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement.

Journal: Frontiers in immunology

Published: January 23, 2019

The importance of therapeutic drug monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for hematopoietic stem cell transplantation (HSCT) in children.

The importance of therapeutic drug monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for hematopoietic stem cell transplantation (HSCT) in children.

Journal: Annals of transplantation

Published: May 09, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026